Antipsychotics at doses >75 mg/day are associated with an increased risk for tardive dyskinesia (TD), according to a study.
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...
The Food and Drug Administration approved the pill from Vertex Pharmaceuticals for acute pain that often occurs after surgery ...
The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.